← All trials
NCT04856787
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 22, 2021
- Primary completion
- Nov 6, 2022
- Completion date
- Nov 6, 2024
- First posted
- Apr 23, 2021
- Last posted
- Jul 13, 2021
- Enrollment
- 439
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.Lead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.